Report for 2022 on the results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products

The report summarises the monitoring data collected in 2022 on the presence of residues of veterinary medicinal products and certain substances in live animals and animal products in the EU Member States, Iceland and Norway. A total of 600,320 samples were reported to the European Commission. They consisted of 342,850 targeted samples and 3,892 suspect samples reported under Council Directive 96/23/EC, and of 2,772 samples collected at import and 250,806 samples collected in the framework of programmes developed under the national legislation. The majority of countries fulfilled the minimum requirements for sampling frequency laid down in Council Directive 96/23/EC and in Commission Decision 97/747/EC. Overall, the percentage of non‐compliant samples in 2022 (0.18%) was comparable to the previous 13 years (0.17%‐0.37%).